Literature DB >> 26310265

Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator.

Khang-Li Looi1, Anthony Tang2, Sharad Agarwal3.   

Abstract

In the era of widespread use of implantable cardioverter-defibrillators (ICDs) for both primary and secondary prevention of sudden cardiac death, a significant proportion of patients experience episodes of multiple ventricular tachycardia/fibrillation over a short period of time requiring device interventions. The episodes are termed ventricular arrhythmia (VA) or electrical storms. VA storm is a tragic experience for patients, with many psychological consequences. Current management for VA storms remains complex. Acutely, administration of β-blockers, amiodarone and sedation or intubation is generally required to suppress sympathetic tone. Interventional treatment includes catheter ablation and sympathetic blockade by left cardiac sympathetic denervation. Strategies to modify autonomic tone to suppress VAs are the rationale of various novel interventions that have been published in recent studies. All patients with VA storm should be considered for transfer to an experienced high-volume tertiary centre for evaluation and treatment to prevent further recurrence of VA storm. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26310265     DOI: 10.1136/postgradmedj-2015-133550

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  3 in total

1.  Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.

Authors:  Yasuhito Kotake; Chrishan J Nalliah; Timothy Campbell; Richard G Bennett; Samual Turnbull; Saurabh Kumar
Journal:  J Interv Card Electrophysiol       Date:  2021-11-17       Impact factor: 1.900

2.  An inappropriate pacing threshold increase after repeated electrical storm in a patient with implantable cardioverter defibrillator.

Authors:  Ye Zhu; Xiang Gu; Chao Xu
Journal:  BMC Cardiovasc Disord       Date:  2017-10-16       Impact factor: 2.298

3.  Amiodarone in the treatment of atrial fibrillation of patients with rheumatic heart disease after valve replacement.

Authors:  Kebiao Chen; Li Qin; Xin Lu; Tao Xia; Qing Gu
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.